Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium

NCT02866370 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Clear Cell Carcinoma
Endometrial Clear Cell Carcinoma

Interventions

DRUG: Nintedanib
DRUG: Paclitaxel
DRUG: Pegylated Liposomal Doxorubicin (PLD)
DRUG: Topotecan
DRUG: Carboplatin
DRUG: Doxorubicin

Sponsor

NHS Greater Glasgow and Clyde

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]